Explore strategies to minimize off-target edits in gene editing experiments during this one-hour webinar presented by Kevin Pridham, a Field Applications Scientist at Thermo Fisher Scientific. Learn about best practices for using engineered nucleases like CRISPR-Cas9 to create cell-based disease models, animal models, and cell therapies while addressing concerns about off-target cleavage. Discover considerations for different experimental scenarios and how Thermo Fisher Scientific is optimizing the gene editing workflow. Gain insights from Pridham's extensive background in cancer biology, drug development, and neurobiology. Earn PACE credits by watching the webinar and following the provided instructions. Connect with LabRoots on various social media platforms for more scientific content and updates.
Considerations to Limit Off-Target Edits in Gene Editing Experiments
Overview
Syllabus
Considerations to Limit Off-Target Edits in your Gene Editing Experiments
Taught by
Labroots
Related Courses
-
From Bench to Bedside: Targeted Gene Editing
-
CRISPR - Cas9 Gene Therapy and CAR T-Cell Therapy - Promising?
-
CRISPR - 10 Years of Genome Editing and More
4.0 -
Physicochemical and Functional Characterization of Different Engineered Cas9 Variants and CRISPR-Cas9 Ribonucleoprotein Complexes
-
Unveiling the Potential of CRISPR: A Guide to Gene Editing
-
Expanding the Frontiers of Gene Editing: The Role of Genotypic Confirmation
